세계의 아페레시스 장비 시장 규모 및 예측 : 제품별, 용도별, 시술별, 기술별, 지역별 분석(2023-2030년)

Global Apheresis Equipment Market is valued at approximately USD 2.66 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 9.20% over the forecast period 2023-2030. Apheresis equipment is a medical technology used for a procedure called apheresis, which involves the separation and collection of specific components of blood. This equipment typically includes a machine with specialized tubing sets and filters that allow for the separation of blood into its various components, such as red blood cells, plasma, platelets, and white blood cells. These devices are designed to ensure the safe and efficient collection of specific blood components for therapeutic purposes, such as treating certain medical conditions or preparing blood products for transfusion. The Apheresis Equipment market is expanding because of factors such as the rising prevalence of blood-related disorders, rising popularity & participation in blood donation drives & camps, and favorable government initiatives along with reimbursement frameworks.

Chronic myeloid leukemia (CML) is a type of blood cancer that affects the bone marrow, leading to the overproduction of abnormal white blood cells. In some cases, patients with CML may require stem cell transplants as part of their treatment regimen. Apheresis equipment plays a crucial role in the collection of hematopoietic stem cells from donors or patients for transplantation. As the prevalence of CML increases, so does the demand for stem cell transplants, thereby driving the need for apheresis equipment. According to the Leukemia & Lymphoma Society (LLS) 2021, approximately every three minutes, one person in the United States is diagnosed with blood cancer. The new cases of leukemia, lymphoma, and myeloma accounted for 9.8% of the total 1,898,160 new cancer cases diagnosed in the United States in 2021. Moreover, according to the National Library of Medicine, the prevalence of chronic myeloid leukemia (CML) across the globe was 112,000 in the year 2020, and it is projected to increase to 144,000 by the year 2030, and 167,000 by the year 2040 and 181,000 cases by the year 2050. The rising prevalence of chronic myeloid leukemia across the globe is driving the market growth. In addition, rising R&D investments by biopharmaceutical companies and the growing field of regenerative medicine are some factors creating new opportunities for market growth. However, the high cost of apheresis equipment and stringent regulatory requirements stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Apheresis Equipment Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the widespread occurrence of blood-related disorders and the need for blood components. Primary users encompass hospitals, clinics, and blood donation centers. Leading market players such as B. Braun Melsungen AG, Haemonetics Corp., and Fresenius Kabi AG are actively engaged in mergers and acquisitions to consolidate their positions. Within North America, the U.S. stands out as a dominant force owing to its advanced healthcare infrastructure. Anticipated trends include ongoing technological innovations and heightened awareness initiatives, which are poised to sustain market expansion. Asia Pacific is expected to grow at the fastest during the forecast period, owing to factors such as escalating incidence of blood disorders necessitating plasma and platelet transfusions in emerging economies like India and China underscores the growth trajectory. Furthermore, the enhancement of healthcare infrastructure and the rising count of healthcare professionals in these regions are poised to provide a solid foundation for substantial industry expansion throughout the forecast period.

Major market players included in this report are:

• B. Braun Melsungen AG
• Haemonetics Corporation
• Fresenius Kabi AG
• Asahi Kasei Medical Co., Ltd.
• Terumo BCT, Inc.
• Mallinckrodt Plc
• Nikkiso Europe GmbH
• Medicap clinic GmbH
• Medica SPA
• Kawasumi Laboratories, Inc

Recent Developments in the Market:

• In August 2023, TERUMO BCT, INC. received clearance from the U.S. FDA for its platelet device, which streamlines blood processing into platelets within a single centrifugation cycle.
• In August 2023, Fresenius Kabi AG and Lupagen Inc. signed a supply and development pact aimed at advancing technologies tailored to facilitate the delivery of cell and gene therapies directly to the patient's bedside.

Global Apheresis Equipment Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Product, Application, Procedure, Technology, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the market's future. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Disposable Apheresis Kits
• Devices

By Application:

• Renal Diseases
• Hematology
• Neurology
• Others

By Procedure:

• Plasmapheresis
• Photopheresis
• Leukapheresis
• Plateletpheresis
• LDL Apheresis
• Erythrocytapheresis
• Others

By Technology:

• Membrane Filtration
• Centrifugation

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Apheresis Equipment Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2.Apheresis Equipment Market, by Product, 2020-2030 (USD Billion)
  • 1.2.3.Apheresis Equipment Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4.Apheresis Equipment Market, by Procedure, 2020-2030 (USD Billion)
  • 1.2.5.Apheresis Equipment Market, by Technology, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Apheresis Equipment Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Apheresis Equipment Market Dynamics

• 3.1.Apheresis Equipment Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Rising Prevalence of Blood-Related Disorders
    • 3.1.1.2.Rising Popularity & Participation in Blood Donation Drives & Camps
    • 3.1.1.3.Favorable Government Initiatives along with Reimbursement Frameworks
  • 3.1.2.Market Challenges
    • 3.1.2.1.High Cost of Apheresis Equipment
    • 3.1.2.2.Stringent Regulatory Requirements
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Rising R&D Investments by Biopharmaceutical Companies
    • 3.1.3.2.Advancements in Field of Regenerative Medicine

Chapter 4.Global Apheresis Equipment Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Apheresis Equipment Market, by Product

• 5.1.Market Snapshot
• 5.2.Global Apheresis Equipment Market by Product, Performance - Potential Analysis
• 5.3.Global Apheresis Equipment Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 5.4.Apheresis Equipment Market, Sub Segment Analysis
  • 5.4.1. Disposable Apheresis Kits
  • 5.4.2.Devices

Chapter 6.Global Apheresis Equipment Market, by Application

• 6.1.Market Snapshot
• 6.2.Global Apheresis Equipment Market by Application, Performance - Potential Analysis
• 6.3.Global Apheresis Equipment Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4.Apheresis Equipment Market, Sub Segment Analysis
  • 6.4.1. Renal Diseases
  • 6.4.2.Hematology
  • 6.4.3.Neurology
  • 6.4.4.Others

Chapter 7.Global Apheresis Equipment Market, by Procedure

• 7.1.Market Snapshot
• 7.2.Global Apheresis Equipment Market by Procedure, Performance - Potential Analysis
• 7.3.Global Apheresis Equipment Market Estimates & Forecasts by Procedure 2020-2030 (USD Billion)
• 7.4.Apheresis Equipment Market, Sub Segment Analysis
  • 7.4.1. Plasmapheresis
  • 7.4.2.Photopheresis
  • 7.4.3.Leukapheresis
  • 7.4.4.Plateletpheresis
  • 7.4.5.LDL Apheresis
  • 7.4.6.Erythrocytapheresis
  • 7.4.7.Others

Chapter 8.Global Apheresis Equipment Market, by Technology

• 8.1.Market Snapshot
• 8.2.Global Apheresis Equipment Market by Technology, Performance - Potential Analysis
• 8.3.Global Apheresis Equipment Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
• 8.4.Apheresis Equipment Market, Sub Segment Analysis
  • 8.4.1. Membrane Filtration
  • 8.4.2.Centrifugation

Chapter 9.Global Apheresis Equipment Market, Regional Analysis

• 9.1.Top Leading Countries
• 9.2.Top Emerging Countries
• 9.3.Apheresis Equipment Market, Regional Market Snapshot
• 9.4.North America Apheresis Equipment Market
  • 9.4.1.U.S. Apheresis Equipment Market
    • 9.4.1.1.Product breakdown estimates & forecasts, 2020-2030
    • 9.4.1.2.Application breakdown estimates & forecasts, 2020-2030
    • 9.4.1.3.Procedure breakdown estimates & forecasts, 2020-2030
    • 9.4.1.4.Technology breakdown estimates & forecasts, 2020-2030
  • 9.4.2.Canada Apheresis Equipment Market
• 9.5.Europe Apheresis Equipment Market Snapshot
  • 9.5.1.U.K. Apheresis Equipment Market
  • 9.5.2.Germany Apheresis Equipment Market
  • 9.5.3.France Apheresis Equipment Market
  • 9.5.4.Spain Apheresis Equipment Market
  • 9.5.5.Italy Apheresis Equipment Market
  • 9.5.6.Rest of Europe Apheresis Equipment Market
• 9.6.Asia-Pacific Apheresis Equipment Market Snapshot
  • 9.6.1.China Apheresis Equipment Market
  • 9.6.2.India Apheresis Equipment Market
  • 9.6.3.Japan Apheresis Equipment Market
  • 9.6.4.Australia Apheresis Equipment Market
  • 9.6.5.South Korea Apheresis Equipment Market
  • 9.6.6.Rest of Asia Pacific Apheresis Equipment Market
• 9.7.Latin America Apheresis Equipment Market Snapshot
  • 9.7.1.Brazil Apheresis Equipment Market
  • 9.7.2.Mexico Apheresis Equipment Market
• 9.8.Middle East & Africa Apheresis Equipment Market
  • 9.8.1.Saudi Arabia Apheresis Equipment Market
  • 9.8.2.South Africa Apheresis Equipment Market
  • 9.8.3.Rest of Middle East & Africa Apheresis Equipment Market

Chapter 10.Competitive Intelligence

• 10.1.Key Company SWOT Analysis
• 10.2.Top Market Strategies
• 10.3.Company Profiles
  • 10.3.1. B. Braun Melsungen AG
    • 10.3.1.1.Key Information
    • 10.3.1.2.Overview
    • 10.3.1.3.Financial (Subject to Data Availability)
    • 10.3.1.4.Product Summary
    • 10.3.1.5.Recent Developments
  • 10.3.2. Haemonetics Corporation
  • 10.3.3.Fresenius Kabi AG
  • 10.3.4.Asahi Kasei Medical Co., Ltd.
  • 10.3.5.Terumo BCT, Inc.
  • 10.3.6.Mallinckrodt Plc
  • 10.3.7.Nikkiso Europe GmbH
  • 10.3.8.Medicap clinic GmbH
  • 10.3.9.Medica SPA
  • 10.3.10.Kawasumi Laboratories, Inc

Chapter 11.Research Process

• 11.1.Research Process
  • 11.1.1.Data Mining
  • 11.1.2.Analysis
  • 11.1.3.Market Estimation
  • 11.1.4.Validation
  • 11.1.5.Publishing
• 11.2.Research Attributes
• 11.3.Research Assumption